References
- WHOThe top 10 causes of death [internet]Fact sheet N°310GenevaWHO2014 Available from: http://www.who.int/mediacentre/factsheets/fs310/en/Accessed October 05, 2016
- ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
- CamiciottoliGBigazziFMagniCPrevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2016112229223627695310
- MüllerovaHAgustiAErqouSMapelDWCardiovascular comorbidity in COPD: systematic literature reviewChest201314441163117823722528
- FinkelsteinJChaEScharfSMChronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidityInt J Chron Obstruct Pulmon Dis2009433734919802349
- YinLLensmarCIngelssonEBackMDifferential association of chronic obstructive pulmonary disease with myocardial infarction and ischemic stroke in a nation-wide cohortInt J Cardiol2014173360160324704409
- MenezesAMPérez-PadillaRWehrmeisterFCPLATINO teamFEV1 is a better predictor of mortality than FVC: the PLATINO cohort studyPLoS One2014910e10973225285441
- LindbergALarssonLGMuellerovaHRönmarkELundbäckBUp-to-date on mortality in COPD – report from the OLIN COPD studyBMC Pulm Med201212122230685
- ManninoDMBuistASPettyTLEnrightPLReddSCLung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up studyThorax200358538839312728157
- From the Global Strategy for the Diagnosis MaPoCGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: http://www.goldcopd.orgAccessed June 30, 2017
- BerryCEWiseRAMortality in COPD: causes, risk factors, and preventionCOPD20107537538220854053
- SinDDWuLManSFThe relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literatureChest200512761952195915947307
- JørgensenPGJensenJSMarottJLJensenGBAppleyardMMogelvangRElectrocardiographic changes improve risk prediction in asymptomatic persons age 65 years or above without cardiovascular diseaseJ Am Coll Cardiol201464989890625169175
- OstörESchnohrPJensenGNyboeJHansenATElectrocardiographic findings and their association with mortality in the Copenhagen City Heart StudyEur Heart J1981243173287297572
- De BacquerDDe BackerGKornitzerMBlackburnHPrognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and womenHeart199880657057710065025
- RollinAMauryPKeeFIsolated negative T waves in the general population is a powerful predicting factor of cardiac mortality and coronary heart diseaseInt J Cardiol201620331832426523363
- AuerRBauerDCMarques-VidalPHealth ABC StudyAssociation of major and minor ECG abnormalities with coronary heart disease eventsJAMA2012307141497150522496264
- ChouRAroraBDanaTFuRWalkerMHumphreyLScreening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task ForceAnn Intern Med2011155637538521930855
- VanfleterenLEFranssenFMUszko-LencerNHFrequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary diseaseAm J Cardiol2011108111669167422077976
- NilssonUJohanssonBErikssonBBlombergALundbäckBLindbergAIschemic heart disease among subjects with and without chronic obstructive pulmonary disease – ECG-findings in a population-based cohort studyBMC Pulm Med20151515626637314
- LangePMogelvangRMarottJLVestboJJensenJSCardiovascular morbidity in COPD: a study of the general populationCOPD20107151020214458
- Antonelli IncalziRFusoLDe RosaMCo-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary diseaseEur Respir J19971012279428009493663
- LindbergALundbäckBThe Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortalityClin Respir J20082Suppl 1647120298352
- PrineasRJCrowRSBlackburnHWThe Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classificationBoston, MAJohn Wright-PSG1982
- Standardization of Spirometry, 1994 Update. American Thoracic SocietyAm J Respir Crit Care Med19951523110711367663792
- BackmanHLindbergAOdénAReference values for spirometry – report from the Obstructive Lung Disease in Northern Sweden studiesEur Clin Respir J2015226375
- CollSBetriuAde FloresTSignificance of Q-wave regression after transmural acute myocardial infarctionAm J Cardiol198861107397423354435
- KurlSMakikallioTHLaukkanenJAT-wave inversion and mortality riskAnn Med2015471697325613172
- GoudisCAKonstantinidisAKNtalasIVKorantzopoulosPElectrocardiographic abnormalities and cardiac arrhythmias in chronic obstructive pulmonary diseaseInt J Cardiol201519926427326218181
- LamprechtBSorianoJBStudnickaMDeterminants of underdiagnosis of COPD in national and international surveysChest2015148497198525950276
- JohnstonAKManninoDMHaganGWDavisKJKiriVARelationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohortThorax200863759960518245145
- FranssenFMSorianoJBRocheNLung function abnormalities in smokers with ischemic heart diseaseAm J Respir Crit Care Med2016194556857627442601
- CampoGGuastarobaPMarzocchiAImpact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary interventionChest2013144375075723392738
- WakabayashiKGonzalezMADelhayeCImpact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarctionAm J Cardiol2010106330530920643237
- AndellPKoulSMartinssonAImpact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarctionOpen Heart201411e00000225332773
- MiravitllesMVogelmeierCRocheNA review of national guidelines for management of COPD in EuropeEur Respir J201647262563726797035
- MoyerVAU.S. Preventive Services Task Force. Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statementAnn Intern Med2012157751251822847227
- ShahAJVaccarinoVJanssensACAn electrocardiogram-based risk equation for incident cardiovascular disease from the National Health and Nutrition Examination SurveyJAMA Cardiol20161777978627487404
- SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J20062861245125717138679
- ErikssonBLindbergAMüllerovaHRönmarkELundbäckBAssociation of heart diseases with COPD and restrictive lung function – results from a population surveyRespir Med201310719810623127573
- FordESWheatonAGManninoDMPresley-CantrellLLiCCroftJBElevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010Respir Res20121311523237325
- BackmanHErikssonBHedmanLRestrictive spirometric pattern in the general adult population: methods of defining the condition and consequences on prevalenceRespir Med201612011612327817808
- HardieJABuistASVollmerWMEllingsenIBakkePSMørkveORisk of over-diagnosis of COPD in asymptomatic elderly never-smokersEur Respir J20022051117112212449163